Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis

European Respiratory Journal

Volumn 33, Issue 1, 2009, Pages 99-106

  Troosters, T ^a,b   Langer, D ^a,b   Vrijsen, B ^a,b   Segers, J ^b   Wouters, K ^b   Janssens, W ^a   Gosselink, R ^a,b   Decramer, M ^a,b   Dupont, L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Adults; Cystic fibrosis; Exercise tolerance; Physical activity; Skeletal muscle

Indexed keywords

OXYGEN;

ADULT; ARTICLE; BREATHING MUSCLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENERGY EXPENDITURE; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; MUSCLE FORCE; MUSCLE STRENGTH; MUSCLE WEAKNESS; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SKELETAL MUSCLE; WALKING;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; CYSTIC FIBROSIS; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MOTOR ACTIVITY; MUSCLE WEAKNESS; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PREVALENCE; YOUNG ADULT;

EID: 58849126911     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00091607     Document Type: Article

References (38)

1. Boyle MP. Update on maintaining bone health in cystic fibrosis. Curr Opin Pulm Med 2006; 12: 453-458.
2. Orenstein DM, Higgins LW. Update on the role of exercise in cystic fibrosis. Curr Opin Pulm Med 2005; 11: 519-523.
3. Dodd JD, Barry SC, Gallagher CG. Respiratory factors do not limit maximal symptom-limited exercise in patients with mild cystic fibrosis lung disease. Respir Physiol Neurobiol 2006; 152: 176-185.
4. Dodd JD, Barry SC, Daly LE, Gallagher CG. Inhaled β-agonists improve lung function but not maximal exercise capacity in cystic fibrosis. J Cyst Fibros 2005; 4: 101-105.
5. de Meer K, Gulmans VAM, van der Laag J. Peripheral muscle weakness and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med 1999; 159: 748-754.
6. Moser C, Tirakitsoontorn P, Nussbaum E, Newcomb R, Cooper DM. Muscle size and cardiorespiratory response to exercise in cystic fibrosis. Am J Respir Crit Care Med 2000; 162: 1823-1827.
7. Shah AR, Gozal D, Keens TG. Determinants of aerobic and anaerobic exercise performance in cystic fibrosis. Am J Respir Crit Care Med 1998; 157: 1145-1150.
8. Hussey J, Gormley J, Leen G, Greally P. Peripheral muscle strength in young males with cystic fibrosis. J Cyst Fibros 2002; 1: 116-121.
9. Pinet C, Cassart M, Scillia P, et al. Function and bulk of respiratory and limb muscles in patients with cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 989-994.
10. Elkin SL, Williams L, Moore M, Hodson ME, Rutherford OM. Relationship of skeletal muscle mass, muscle strength and bone mineral density in adults with cystic fibrosis. Clin Sci (Lond) 2000; 99: 309-314.
11. Sahlberg ME, Svantesson U, Thomas EM, Strandvik B. Muscular strength and function in patients with cystic fibrosis. Chest 2005; 127: 1587-1592.
12. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Collins CE, Garg ML. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 2001; 20: 157-165.
13. Gupta A, Eastham KM, Wrightson N, Spencer DA. Hypomagnesaemia in cystic fibrosis patients referred for lung transplant assessment. J Cyst Fibros 2007; 6: 360-362.
14. Hebestreit H, Kieser S, Rudiger S, et al. Physical activity is independently related to aerobic capacity in cystic fibrosis. Eur Respir J 2006; 28: 734-739.
15. Selvadurai HC, Blimkie CJ, Cooper PJ, Mellis CM, Van Asperen PP. Gender differences in habitual activity in children with cystic fibrosis. Arch Dis Child 2004; 89: 928-933.
16. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
17. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969; 99: 696-702.
18. Rochester DF, Arora NS. Respiratory muscle failure. Med Clin North Am 1983; 67: 573-597.
19. Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985; 66: 69-74.
20. Decramer M, de Bock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1958-1964.
21. Jones NL, ed. Clinical Exercise Testing. 3rd Edn. WB Saunders, Philadelphia, 1988.
22. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999; 14: 270-274.
23. Gibbons WJ, Fruchter N, Sloan S, Levy RD. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 2001; 21: 87-93.
24. St-Onge M, Mignault D, Allison DB, Rabasa-Lhoret R. Evaluation of a portable device to measure daily energy expenditure in free-living adults. Am J Clin Nutr 2007; 85: 742-749.
25. US Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. 1996.
26. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116: 1081-1093.
27. Tudor-Locke C, Bassett DR Jr. How many steps/day are enough? Preliminary pedometer indices for public health. Sports Med 2004; 34: 1-8.
28. Enright S, Chatham K, Ionescu AA, Unnithan VB, Shale DJ. The influence of body composition on respiratory muscle, lung function and diaphragm thickness in adults with cystic fibrosis. J Cyst Fibros 2007; 6: 384-390.
29. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-980.
30. Booth FW, Gordon SE, Carlson CJ, Hamilton MT. Waging war on modern chronic diseases: primary prevention through exercise biology. J Appl Physiol 2000; 88: 774-787.
31. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 972-977.
32. American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 1998; 30: 975-991.
33. Haworth CS, Selby PL, Webb AK, et al. Low bone mineral density in adults with cystic fibrosis. Thorax 1999; 54: 961-967.
34. Street ME, Spaggiari C, Ziveri MA, et al. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines. Horm Res 2006; 66: 162-168.
35. Ionescu AA, Mickleborough TD, Bolton CE, et al. The systemic inflammatory response to exercise in adults with cystic fibrosis. J Cyst Fibros 2006; 5: 105-112.
36. Barry SC, Gallagher CG. Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol 2003; 95: 1379-1384.
37. Spruit M, Gosselink R, Troosters T, et al. Muscle force during an acute exacerbation in hospitalised COPD patients and its relationship with CXCL8 and IGF-1. Thorax 2003; 58: 752-756.
38. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006; 129: 536-544.